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MaBACKGROUND Public reporting of procedural outcomes may create disincentives to provide percutaneous coronary
intervention (PCI) for critically ill patients.
OBJECTIVES This study evaluated the association between public reporting with procedural management and
outcomes among patients with acute myocardial infarction (AMI).
METHODS Using the Nationwide Inpatient Sample, we identiﬁed all patients with a primary diagnosis of AMI in
states with public reporting (Massachusetts and New York) and regionally comparable states without public reporting
(Connecticut, Maine, Maryland, New Hampshire, Rhode Island, and Vermont) between 2005 and 2011. Procedural
management and in-hospital outcomes were stratiﬁed by public reporting.
RESULTS Among 84,121 patients hospitalized with AMI, 57,629 (69%) underwent treatment in a public reporting state.
After multivariate adjustment, percutaneous revascularization was performed less often in public reporting states than in
nonreporting states (odds ratio [OR]: 0.81, 95% conﬁdence interval [CI]: 0.67 to 0.96), especially among older patients
(OR: 0.75, 95% CI: 0.62 to 0.91), those with Medicare insurance (OR: 0.75, 95% CI: 0.62 to 0.91), and those presenting
with ST-segment elevation myocardial infarction (OR: 0.63, 95% CI: 0.56 to 0.71) or concomitant cardiac arrest or
cardiogenic shock (OR: 0.58, 95% CI: 0.47 to 0.70). Overall, patients with AMI in public reporting states had higher
adjusted in-hospital mortality rates (OR: 1.21, 95% CI: 1.06 to 1.37) than those in nonreporting states. This was observed
predominantly in patients who did not receive percutaneous revascularization in public reporting states (adjusted OR:
1.30, 95% CI: 1.13 to 1.50), whereas those undergoing the procedure had lower mortality (OR: 0.71, 95% CI: 0.62 to 0.83).
CONCLUSIONS Public reporting is associated with reduced percutaneous revascularization and increased in-hospital
mortality among patients with AMI, particularly among patients not selected for PCI. (J Am Coll Cardiol 2015;65:1119–26)
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ABBR EV I A T I ON S
AND ACRONYMS
AMI = acute myocardial
infarction
CI = conﬁdence interval
ICID-9-CM = International
Classiﬁcation of Diseases-Ninth
Revision-Clinical Modiﬁcation
IQR = interquartile range
NIS = nationwide inpatient
sample
NSTEMI = non–ST-segment
elevation myocardial infarction
OR = odds ratio
PCI = percutaneous coronary
intervention
STEMI = ST-segment elevation
myocardial infarction
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1120currently considering or have recently imple-
mented public reporting programs, with the
intent of improving clinical performance for
patients receiving this therapy (3). Evidence
suggests that public reporting of outcomes
may lead to improvements in the quality of
care for cardiovascular procedures (4). How-
ever, it may also create disincentives for phy-
sicians to provide care for the most critically
ill patients, as mortality in such individuals
remains high despite treatment with appro-
priate guideline-based care (5–9).SEE PAGE 1127Prior investigations have demonstrated
that Medicare patients presenting with AMI
are less likely to undergo percutaneous
revascularization in a state that participatesin public reporting of hospital outcomes, despite a
consensus that such therapy is indicated (1,2,10). The
decreased rate of PCI observed in public reporting
states was not associated with an increase in overall
mortality, leading to speculation that public reporting
of risk-adjusted mortality primarily reduced futile or
otherwise unnecessary procedures. Subgroup anal-
ysis of the same cohort, however, demonstrated a
greater likelihood of death following a ST-segment
elevation myocardial infarction (STEMI) for Medi-
care patients treated in public reporting states than
for those in nonreporting states (10). Whether this
phenomenon is occurring across all ages and insur-
ance payers is unknown.
The present study sought to evaluate the associa-
tion between public reporting with procedural man-
agement and outcomes among a diverse population
of patients with AMI. To do so, we used the Nation-
wide Inpatient Sample (NIS) to identify a represen-
tative sample of myocardial infarction patients that
included all ages and multiple payers.
METHODS
POPULATION. The NIS is an annual database derived
from a sample of all nonrehabilitation hospital stays
in the United States. The population within this
database was stratiﬁed based on the presence or
absence of public reporting of PCI outcomes. Subjects
hospitalized in Massachusetts and New York com-
prised the public reporting group, whereas those
hospitalized in Connecticut, Maine, Maryland, Rhode
Island, and Vermont served as the control cohort of
regional states that do not publicly report PCI out-
comes, consistent with prior analyses (10). Pennsyl-
vania and New Jersey were excluded from thisanalysis as they have been collecting but inconsis-
tently reporting outcomes to the public during the
period under investigation. Furthermore, Pennsyl-
vania has been inconsistently contributing data to the
NIS during the study period. Among hospitalizations
identiﬁed in these states, we identiﬁed all patients
with a primary discharge diagnosis of AMI from
2005 to 2011, using the International Classiﬁcation of
Diseases - Ninth Revision - Clinical Modiﬁcation (ICD-
9-CM) codes. Acute myocardial infarction was deﬁned
as a primary discharge diagnosis of non–ST-segment
elevation myocardial infarction (NSTEMI; codes
410.71 and 410.91) or STEMI (codes 410.11 to 410.61
and 410.81). Subjects who were hospitalized at facil-
ities that did not offer PCI were excluded from anal-
ysis. Furthermore, patients transferred out of a given
facility also were excluded to ensure an accurate
assessment of in-hospital outcomes.
MEASUREMENTS. Demographic characteristics, in-
cluding patient age, sex, and race, were derived from
the dataset. High-risk features that could complicate
procedural management such as cardiac arrest (code
427.5) and cardiogenic shock (code 785.51) were also
assessed. To evaluate procedural management of
patients with this diagnosis, the dataset was queried
for procedural codes for percutaneous coronary
intervention (ICD-9-CM codes 00.66, 17.55, 36.01,
36.02, 36.05, 36.06, and 36.07) and surgical revascu-
larization via coronary artery bypass grafting (ICD-9-
CM codes 36.10 to 36.19).
ANALYSIS. Summary statistics were reported as
mean  SD for continuous variables or medians
and interquartile ranges (IQR) for non-normally
distributed continuous data. To account for varia-
tion due to sampling, discharge weights were applied
to the dataset based on methods established by the
Healthcare Cost and Utilization Project (11). Unad-
justed comparisons were made using the Proc Survey
Logistic feature, which accounts for the complex
survey design of NIS data. Adjusted logistic regres-
sion models with clustering by hospital were subse-
quently created that included age, sex, race, and 29
comorbid medical conditions identiﬁed by the risk
adjustment model developed by the Agency for
Healthcare Research and Quality (Online Table 1).
This model was then used to assess the relationship
between public reporting and percutaneous revascu-
larization, which represents the most common mo-
dality for revascularization in myocardial infarction
patients. To determine whether the association be-
tween public reporting and likelihood of percuta-
neous revascularization differed based on the risk
proﬁle of patients, we introduced interaction terms
TABLE 1 Characteristics of Patients With Acute Myocardial Infarction,
2005 to 2011
Public Reporting
(n ¼ 57,629)
Nonreporting
(n ¼ 26,492) p Value
Age, yrs 68.0  14.7 67.4  14.6 0.200
Female 22,786 (40) 10,758 (41) 0.078
White 40,935 (71) 20,137 (76) 0.032
Presentation 0.689
Non-ST-segment elevation MI 40,388 (70) 18,726 (71)
ST-segment elevation MI 17,241 (30) 7,766 (29)
Complications
Cardiac arrest 1,237 (2) 731 (3) <0.001
Cardiogenic shock 2,431 (4) 1,279 (5) 0.025
Primary insurance <0.001
Medicare 33,075 (57) 14,983 (57)
Medicaid 4,961 (9) 1,691 (6)
Private insurance 16,330 (28) 8,373 (32)
Self-pay 1,823 (3) 957 (4)
Other 1,029 (2) 303 (1)
Comorbid conditions
Anemia (blood loss) 499 (1) 404 (2) <0.001
Anemia (deﬁciency) 6,928 (12) 4,132 (16) <0.001
Diabetes (uncomplicated) 16,398 (29) 7,522 (28) 0.910
Diabetes (chronic complications) 2,974 (5) 1,535 (6) 0.052
Hypertension 39,240 (68) 18,026 (68) 0.935
Peripheral vascular disorders 5,260 (9) 3,305 (13) <0.001
Renal failure 8,876 (15) 4,287 (16) 0.326
Values are mean  SD or n (%). Reporting states include Massachusetts and New York.
Nonreporting states include Connecticut, Maine, Maryland, New Hampshire, Rhode Island, and
Vermont.
MI ¼ myocardial infarction.
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1121for selected characteristics including age, primary
insurance, and presentation with a concomitant
STEMI, cardiac arrest, or cardiogenic shock. We also
evaluated the association between public reporting
and in-hospital mortality, using logistic regression
models adjusted for the same set of demographic and
clinical characteristics. To assess whether the associ-
ation between public reporting and mortality differed
based on the performance of percutaneous revascu-
larization, we introduced an interaction term for PCI.
Because coronary artery bypass graft surgery repre-
sents an alternative revascularization procedure for
myocardial infarction, we also examined the associ-
ation between public reporting and surgical re-
vascularization. Finally, a sensitivity analysis was
performed comparing the individual reporting states
(Massachusetts or New York) to the nonreporting
states to evaluate differences in procedural manage-
ment and in-hospital outcomes between the two
public reporting states included in this analysis. For
these analyses, a 3-level categorical variable (New
York versus Massachusetts versus all other non-
reporting states) was included in logistic regression
models for all outcomes. All statistical analyses were
performed using SAS version 9.3 software (SAS Corp.,
Cary, North Carolina). A p value of <0.05 was
considered statistically signiﬁcant.
RESULTS
POPULATION. From 2005 to 2011, 84,121 patients
were hospitalized with AMI in the selected states,
and 57,629 of these patients (69%) received treat-
ment in a facility that publicly reported hospital
outcomes for PCI. The demographic characteristics
of the population stratiﬁed by the presence or ab-
sence of public reporting are presented in Table 1.
Compared with those in nonreporting states, pa-
tients presenting with AMI in a public reporting state
were similar with respect to age and sex but were
signiﬁcantly less likely to have concomitant cardiac
arrest (p < 0.001) or cardiogenic shock (p ¼ 0.025).
Medical comorbidities of the analyzed patient pop-
ulation are summarized in Table 1 and Online
Table 2. The median length of stay in days was
longer for those treated in a public reporting state
(4 days, IQR: 2 to 6 days) than for those treated in
a nonreporting state (3 days, IQR: 2 to 7 days;
p < 0.001).
PERCUTANEOUS REVASCULARIZATION. Percuta-
neous revascularization was performed in 48% of
myocardial infarction patients in reporting states
compared with 51% in nonreporting states (p ¼ 0.209),as shown in the Central Illustration and Online Table 3.
After multivariate adjustment, percutaneous revas-
cularization was performed signiﬁcantly less often in
public reporting states than in nonreporting states
among all patients (odds ratio [OR]: 0.81, 95% conﬁ-
dence interval [CI]: 0.67 to 0.96). These ﬁndings were
speciﬁcally pronounced among patients with older age
(0.75, 95% CI: 0.62 to 0.91), those with Medicare in-
surance (OR: 0.75, 95% CI: 0.62 to 0.91), and those
presenting with STEMI (OR: 0.63, 95% CI: 0.56 to 0.71)
or concomitant cardiac arrest or cardiogenic shock (OR:
0.58, 95% CI: 0.47 to 0.70) in public reporting states
compared with those in nonreporting states (interac-
tion: p < 0.001 for each comparison). A sensitivity
analysis demonstrated similarly reduced odds of un-
dergoing percutaneous revascularization in Massa-
chusetts (OR: 0.88, 95% CI: 0.70 to 1.11) and New York
(OR: 0.77, 95% CI: 0.64 to 0.93) compared with those in
regional nonreporting states. Differences between the
odds of undergoing percutaneous revascularization in
the 2 reporting states did not reach statistical signiﬁ-
cance (p ¼ 0.192). Of note, the adjusted rate of surgical
revascularization for patients in reporting states was
CENTRAL ILLUSTRATION Public Reporting and PCI for AMI: Rates of Percutaneous Intervention and
In-Hospital Mortality for AMI in States With and Without Public Reporting
(Top) Adjusted odds of undergoing percutaneous revascularization among patients with AMI was signiﬁcantly lower in public reporting states
than in nonreporting states (p ¼ 0.017). These ﬁndings were speciﬁcally pronounced among older patients, those with Medicare insurance,
and those presenting with STEMI or concomitant cardiac arrest or cardiogenic shock (interaction p < 0.001 for each comparison). (Bottom)
Adjusted odds of in-hospital mortality among patients with AMI were signiﬁcantly higher in public reporting states than in nonreporting states
(p ¼ 0.003). This ﬁnding was consistent across all ages and insurance carriers, although slightly more prominent among those with a non-
STEMI (interaction: p ¼ 0.035). AMI ¼ acute myocardial infarction; PCI ¼ percutaneous coronary intervention; STEMI ¼ ST-segment elevation
myocardial infarction.
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FIGURE 1 Rate of In-Hospital Mortality for AMI Stratiﬁed by
Public Reporting and PCI, 2005 to 2011
PCI
Non-PCI
0.4 0.6 0.8 1.0 1.2 1.4 1.6
Adjusted Odds Ratios
Lower in Reporting Higher in Reporting
P<0.001
The adjusted odds of mortality were signiﬁcantly lower in public
reporting states among myocardial infarction patients undergo-
ing intervention but signiﬁcantly higher in public reporting states
for patients who did not undergo percutaneous revascularization
(interaction: p < 0.001). AMI ¼ acute myocardial infarction;
PCI ¼ percutaneous coronary intervention.
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1123similar to that for patients in nonreporting states (OR:
1.13, 95% CI: 0.88 to 1.45) (Online Table 4).
The association between public reporting and any
revascularization procedure, that is, percutaneous or
surgical, was attenuated compared with the rate of PCI
alone (OR: 0.88, 95% CI: 0.69 to 1.12 for any revascu-
larization), although rates of any revascularization
continued to be signiﬁcantly lower for those with
STEMI or cardiac arrest/shock in public reporting
states (Online Table 5).
IN-HOSPITAL MORTALITY. The overall in-hospital
mortality of those presenting with AMI was 6%.
Stratifying the population by public reporting, the
mortality rate was 6% of patients in public reporting
states compared with 5% of patients in nonpublic
reporting states. Both the unadjusted (OR: 1.13, 95%
CI: 1.02 to 1.25) and adjusted (OR: 1.21, 95% CI: 1.06 to
1.37) in-hospital mortality rates were signiﬁcantly
greater among patients presenting with AMI in a
public reporting state than for those admitted to a
facility in a nonreporting state (Central Illustration,
Online Table 6). This ﬁnding was consistent across all
ages and insurance carriers, although slightly more
prominent among those with a non–STEMI (interac-
tion: p ¼ 0.035). When patients were stratiﬁed by PCI,
the adjusted odds of mortality was signiﬁcantly lower
in public reporting states among myocardial infarc-
tion patients undergoing intervention (OR: 0.71, 95%
CI: 0.62 to 0.83) but signiﬁcantly higher in public
reporting states for patients who did not undergo
percutaneous revascularization (OR: 1.30, 95% CI: 1.13
to 1.50, interaction: p < 0.001), as shown in Figure 1
and Online Table 7. A sensitivity analysis demon-
strated similarly increased in-hospital mortality in
Massachusetts (OR: 1.21, 95% CI: 1.02 to 1.42) and New
York (OR: 1.21, 95% CI: 1.04 to 1.39) compared with
regional nonreporting states.
DISCUSSION
The present study evaluated the association bet-
ween state-mandated public reporting of hospital
procedural outcomes with procedural management
and in-hospital outcomes among patients presenting
with a myocardial infarction. As shown, patients
treated in a public reporting state are less likely to
undergo percutaneous revascularization, particularly
when they have high-risk features such as older age,
cardiogenic shock, cardiac arrest, or STEMI. In
contrast to previous studies, this is the ﬁrst analysis
that demonstrates increased overall in-hospital mor-
tality after myocardial infarction among patients
treated in public reporting states after multivariateadjustment for the severity of illness (Central
Illustration). Furthermore, the increase in in-hospital
mortality was predominantly isolated to patients
who did not receive percutaneous revascularization,
whereas those selected for the procedure had lower
odds of mortality in public reporting states. Taken
together, these data suggest that public reporting
may improve PCI-related outcomes but may also have
the unintended consequence of increasing risk aver-
sion to the detriment of overall outcomes for patients
with myocardial infarction.
Public reporting is intended to improve outcomes
among patients undergoing percutaneous revascu-
larization. The association between public reporting
and mortality in this population, however, has not
been completely elucidated (12). Previous research
has suggested that unadjusted in-hospital mortality is
lower among patients undergoing PCI in states with
public reporting, a ﬁnding that does not reach nu-
merical or statistical signiﬁcance after adjustment for
signiﬁcant differences in comorbid conditions (13).
Analysis of the Medicare population demonstrated
similar ﬁndings with no differences in 1-month mor-
tality between most myocardial infarction patients
treated in public reporting and nonreporting states,
apart from patients with STEMI (10). In contrast to
these previous studies, the present analysis demon-
strates increased in-hospital mortality for myocardial
infarction patients treated in public reporting states
overall. A sensitivity analysis demonstrated that
these ﬁndings were consistent across both public
reporting states included in this study. The stark
differences in these observations may be a result
of the time period investigated, differences in
patient populations studied, or signiﬁcant differences
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1124between in-hospital and 1-month mortality among
patients with acute infarction. Alternatively, the
increased mortality observed in the present analysis
may reﬂect differential patient selection in public
reporting and nonreporting states, a difference that
could not be detected in the more homogeneous
Medicare population surveyed in previous studies.
Patient selection for percutaneous revasculariza-
tion may differ in public reporting states compared
with that in nonreporting states, resulting in signiﬁ-
cant differences in clinical outcomes. Myocardial
infarction patients selected for percutaneous revas-
cularization in public reporting states had a lower
mortality rate than those in nonreporting states.
These improved outcomes may reﬂect the intended
effect of improvement in PCI quality in these states or
a greater avoidance of futile cases, improving the
observed mortality among those who were selected
for the procedure. However, those who were not
selected for revascularization in public reporting
states had a marked increase in mortality, perhaps
reﬂecting the avoidance of very high-risk cases that
may have, in fact, beneﬁted from revascularization.
Some have argued that the highest risk cases may
have the most to gain from revascularization and that
overall outcomes could be improved if they too were
treated aggressively (14). Regardless, our results
suggest that the triage of AMI patients in public
reporting states differed from the triage in non-
reporting states, a ﬁnding with implications for
health care policy. There is a signiﬁcant need to
develop strategies to combat risk aversion for percu-
taneous revascularization among critically ill patients
with myocardial infarction while maintaining the
important goals of transparency, accountability, and
quality improvement supported by public reporting.
Such strategies may include the continued reﬁne-
ment of risk adjustment models to include unmea-
sured markers of risk (15) or through the exclusion of
the most critically ill patients from performance re-
ports as has been attempted in Massachusetts (16).
Our ﬁndings support the recently published state-
ment from the American Heart Association suggesting
that cardiac arrest patients should be excluded from
public reporting of PCI outcomes, categorizing these
cases as compassionate use of an appropriate treat-
ment in exceptionally high-risk patients (17). The
publicly reported 30-day outcomes for Medicare fee-
for-service patients hospitalized with AMI may play
a role in ensuring that patients receive optimal care,
although the impact of this intervention is unclear. It
is notable that the avoidance of PCI in high-risk pa-
tients that could improve PCI-speciﬁc publicly re-
ported outcomes might result in worse hospitalperformance on this myocardial infarction–speciﬁc
performance metric. Alternate strategies to monitor
outcomes for patients who may be eligible but do not
undergo percutaneous revascularization also should
be considered to ensure that every patient has access
to this therapy.
Current iterations of public reporting may provide
a disincentive for physicians to perform procedures
on sicker patients with a higher likelihood of a poor
outcome. Previous research has suggested that pa-
tients treated for AMI were signiﬁcantly more likely
to undergo coronary angiography and percutaneous
revascularization in a nonreporting state (Michigan)
than in a state with publicly reported outcomes
(New York) (8,13). Furthermore, patients selected for
PCI in the public reporting state had signiﬁcantly
lower rates of cardiogenic shock, congestive heart
failure, or signiﬁcant extracardiac vascular disease
than those treated in a nonreporting state, suggesting
physicians may have avoided higher risk cases when
the outcomes were being monitored. This has been
corroborated in a recent analysis of the Medicare
population, again demonstrating decreased use of
coronary angiography and percutaneous revasculari-
zation for patients with AMI treated in public
reporting states (10). The present study adds to these
data, demonstrating that the overall rates of percu-
taneous revascularization are lower in public report-
ing states than in nonreporting states among all
ages and all insurance payers, particularly for those
with more acute presentations. Interestingly, the
in-hospital mortality differences between reporting
and nonreporting states were more prominent among
patients with less acute presentations. This could be
explained by a higher proportion of patients who
were too ill to beneﬁt from percutaneous revascular-
ization, classiﬁed as having shock or an arrest,
whereas differential treatment among slightly lower
risk patients may have been more inﬂuential to the
overall difference in mortality (18). This explanation
is speculative, however, and the limitations of the
data do not allow for a more rigorous exploration of
this ﬁnding.
STUDY LIMITATIONS. The present study should be
interpreted in the context of several limitations. Pa-
tients were identiﬁed in an administrative dataset
that samples hospitals from a given region each year.
Billing codes were subsequently used to identify pa-
tients with the diagnoses of interest, an imperfect
system that has nevertheless been widely used. The
temporal association between presenting complaints
and comorbid conditions, such as cardiogenic shock
or cardiac arrest, is also ambiguous given the way
PERSPECTIVES
COMPETENCY IN SYSTEMS-BASED PRACTICE: Public
reporting of the outcomes of primary PCI for patients with AMI
is associated with lower likelihood of using PCI and higher
in-hospital mortality.
TRANSLATIONAL OUTLOOK: Better reporting methods
are needed to adequately balance transparency and
accountability with the potential inﬂuence of risk aversion.
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1125data are collated. Furthermore, the sampling scheme
has been designed to be representative of acute care
hospitals but does not necessarily represent all hos-
pitals performing PCI (19). Analyzing temporal trends
in procedural management and in-hospital outcomes
would strengthen the association of our ﬁndings as
well as allow investigation of changes in the public
reporting system during the time period under study.
Unfortunately, the regional sampling process used in
this dataset ensures an adequate representation of
similar hospitals across regions rather than states.
Because of this, a given state could be over- or under-
represented in the sample during a given year, pre-
venting the accurate analysis of temporal trends
within a state. The primary ﬁndings of the study,
however, average the data across several years,
minimizing the effect of sampling (11). Furthermore,
multivariate adjustment for the severity of illness
could only be performed based on claims-based data.
Because of this, it is possible that there are comor-
bidities that differ between reporting and non-
reporting states that are not captured by the dataset
but would explain the differences in procedural
management and outcomes. Similarly, clinical out-
comes within this dataset are limited to the inpatient
setting, and thus a comparison of long-term mortality
could not be performed. Finally, the observational
analysis performed in the present study is only able to
evaluate the association between public reporting
and outcomes and cannot prove causality. Further
studies in other datasets could be performed toovercome these limitations and corroborate our
ﬁndings.
CONCLUSIONS
Public reporting of outcomes is associated with a
lower rate of percutaneous revascularization and
increased overall in-hospital mortality among pa-
tients with AMI, particularly among those who do not
receive PCI. Public reporting of outcomes should
balance the beneﬁts of transparency and account-
ability against the potential inﬂuence of physician
risk aversion.
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